RISK BENEFITS Sample Clauses

RISK BENEFITS. All risk benefits connected to death or disability payable by the PMD Group Companies and/or the Retirement Benefit Arrangements (except the Xxxxxx Xxxxx Group Pension Scheme (UK) and the Stichting Pensioenfonds Xxxxxxxx (NL))are insured in accordance with standard industry practice, if any, in the relevant jurisdiction and no premiums in respect of such insurance are outstanding.
Sample 1
AutoNDA by SimpleDocs
RISK BENEFITS. 6.1. It is a condition of the Loan that the life and the risk of permanent disability of the Borrower / Surety be insured as continuing cover for the Loan. 6.2. The Borrower shall cede to FNB the benefits of an existing policy or a new policy from an authorised life insurance company of its choice, which policy shall, in the sole discretion of FNB, be acceptable to it. FNB will not expect the Borrower / Surety to obtain insurance that would be unreasonable, or for which the cost will be unreasonable for the Borrower / Surety. 6.3. The value of the insurance to be ceded shall not exceed the value of any outstanding amount owing to FNB. 6.4. FNB and the Borrower accept any benefit and obligation to be received by them pursuant to the above insurance. Upon the happening of any insured event, the insurance provider of the Borrower / Surety shall pay to FNB such settlement amount as may be due in terms of FNB’s Agreement with the Borrower / Surety.
Sample 1
RISK BENEFITS. 5.1 The Borrower shall cede to FNB the benefits of an existing policy or a new policy from an authorised life insurance company of its choice, which policy shall, in the sole discretion of FNB, be acceptable to it. FNB will not expect the Borrower / Surety to obtain insurance that would be unreasonable, or for which the cost will be unreasonable for the Borrower / Surety. 5.2 The value of the insurance to be ceded shall not exceed the value of any outstanding amount owing to FNB. 5.3 FNB and the Borrower accept any obligation and benefit to be received by them pursuant to the above insurance. Upon the happening of any insured event, the insurance provider of the Borrower / Surety shall pay to the Bank such settlement amount as may be due in terms of FNB’s Agreement with the Borrower / Surety.
Sample 1
RISK BENEFITS. Cystagon® (cysteamine bitartrate) is a cystine-depleting agent that is the only cystinosis treatment approved by FDA. Cystagon® is indicated for the management of nephropathic cystinosis in children and adults. Cystagon® is contraindicated in patients who have developed hypersensitivity to it or to cysteamine or penicillamine (Cystagon® Package Insert, 2007). The most common adverse events (> 5%) associated with cysteamine were vomiting 35%, anorexia 31%, fever 22%, diarrhea 16%, lethargy 11%, and rash 7% (Cystagon® Package Insert, 2007). Less common adverse events associated with cysteamine include: CNS symptoms such as seizures, dizziness, lethargy, somnolence, depression, and encephalopathy; gastrointestinal tract symptoms including nausea, vomiting, anorexia and abdominal pain, sometimes severe. In addition, gastrointestinal ulceration and bleeding have been reported in patients on cysteamine therapy. Cysteamine has occasionally been associated with reversible leucopenia, abnormal liver function studies, skin lesions, headache, tinnitus, diplopia, blurry vision, loss of vision, pain behind the eye or pain with eye movement (Cystagon® Package Insert, 2007). Patient adherence with Cystagon® is challenging due to significant adverse effects, dosing frequency, and the need for life-long treatment from the age of diagnosis. Since Cystagon® must be taken Q6H around the clock; patients must be awakened in the middle of the night to take their medication in order to maintain adequate white blood cell cystine levels. One recent study demonstrated that only about 25% (5 of 22) of patients were actually adhering to with the Q6H regimen (Xxxxxxxxxx, xxx Xxxx et al. 2006). A Q6H dosing schedule must be maintained for the rest of the patient’s life, therefore preventing patients and / or their caregivers from obtaining a full night’s sleep. Many of these patients are in their formative years where sleep plays a major role in patient well-being and overall health. A change from Q6H to Q12H is not merely for patient convenience, as the Q6H dosing must be adhered to for an entire lifetime, there is evidence that failure to adhere to this strict Q6H dosing regimen results in rapid deterioration of kidney function (Xxxxx, Xxxxxxxxxx et al. 2004). Thus, improved patient adherence will ultimately delay the time to kidney failure or the morbidity and mortality associated with renal replacement therapy such as dialysis or transplant, and hence greatly improves both the patie...
Sample 1

Related to RISK BENEFITS

  • Public Benefits ‌ 5.1 Developer to provide Public Benefits‌ The Developer must, at its cost and risk, provide the Public Benefits to the City in accordance with this document.

  • Insurance Benefits Borrower shall cooperate with Lender in obtaining for Lender the benefits of any Insurance Proceeds lawfully or equitably payable in connection with the Property, and Lender shall be reimbursed for any expenses incurred in connection therewith (including reasonable attorneys' fees and disbursements, and the payment by Borrower of the expense of an appraisal on behalf of Lender in case of a fire or other casualty affecting the Property or any part thereof) out of such Insurance Proceeds.

  • General Benefits During the Term of Employment, the Executive shall be entitled to participate in such employee pension and welfare benefit plans and programs of the Company as are made available to the Company's senior-level executives or to its employees generally, as such plans or programs may be in effect from time to time, including, without limitation, health, medical, dental, long-term disability, travel accident and life insurance plans.

  • Health Benefits For the eighteen (18) month period following the Termination Date, provided that Executive is eligible for, and timely elects COBRA continuation coverage, the Company will pay on Executive’s behalf, the monthly cost of COBRA continuation coverage under the Company’s group health plan for Executive and, where applicable, her spouse and dependents, at the level in effect as of the Termination Date, adjusted for any increase in such level paid by the Company for active employees, less the employee portion of the applicable premiums that Executive would have paid had she remained employed during the such eighteen (18) month period (the COBRA continuation coverage period shall run concurrently with the eighteen (18) month period that COBRA premium payments are made on Executive’s behalf under this subsection 1(a)(ii)). The reimbursements described herein shall be paid in monthly installments, commencing on the sixtieth (60th) day following the Termination Date, provided that the first such installment payment shall include any unpaid reimbursements that would have been made during the first sixty (60) days following the Termination Date. Notwithstanding the foregoing, the Company’s payment of the monthly COBRA premiums in accordance with this subsection 1(a)(ii) shall cease immediately upon the earlier of: (A) the end of the eighteen (18) month period following the Termination Date, or (B) the date that Executive is eligible for comparable coverage with a subsequent employer. Executive agrees to notify the Company in writing immediately if subsequent employment is accepted prior to the end of the eighteen (18) month period following the Termination Date and Executive agrees to repay to the Company any COBRA premium amount paid on Executive’s behalf during such period for any period of employment during which group health coverage is available through a subsequent employer. Notwithstanding the foregoing, the Company reserves the right to restructure the foregoing COBRA premium payment arrangement in any manner necessary or appropriate to avoid fines, penalties or negative tax consequences to the Company or Executive (including, without limitation, to avoid any penalty imposed for violation of the nondiscrimination requirements under the Patient Protection and Affordable Care Act or the guidance issued thereunder), as determined by the Company in its sole and absolute discretion.

  • Covered Benefits Benefits for Bone Mass Measurement for the prevention, diagnosis, and treatment of osteoporosis are covered when requested by a Health Care Provider for a Qualified Individual.

  • Group Benefits To determine if a leave under the provisions of the Family and Medical Leave Act will be a paid or unpaid leave, contact the District’s Human Resources Department.

  • Medical Benefits The Company shall reimburse the Employee for the cost of the Employee's group health, vision and dental plan coverage in effect until the end of the Termination Period. The Employee may use this payment, as well as any other payment made under this Section 6, for such continuation coverage or for any other purpose. To the extent the Employee pays the cost of such coverage, and the cost of such coverage is not deductible as a medical expense by the Employee, the Company shall "gross-up" the amount of such reimbursement for all taxes payable by the Employee on the amount of such reimbursement and the amount of such gross-up.

  • Group Insurance Benefits To determine if a leave under the provisions of the Family and Medical Leave Act will be paid or unpaid leave of absence contact the school district Employee Benefits Department.

  • Standard Benefits During the Employment Period, Executive shall be entitled to participate in all employee benefit plans and programs, including paid vacations, generally available to other similarly situated Company executives, subject to the terms and conditions of the applicable plans.

  • Retiree Health Benefits 1. There is currently in effect a retiree health benefit program for retired members of LACERS under LAAC Division 4, Chapter 11. All covered employees who are members of LACERS, regardless of retirement tier, shall contribute to LACERS four percent (4%) of their pre-tax compensation earnable toward vested retiree health benefits as provided by this program. The retiree health benefit available under this program is a vested benefit for all covered employees who make this contribution, including employees enrolled in LACERS Tier 3. 2. With regard to LACERS Tier 1, as provided by LAAC Section 4.1111, the monthly Maximum Medical Plan Premium Subsidy, which represents the Kaiser 2-party non-Medicare Part A and Part B premium, is vested for all members who made the additional contributions authorized by LAAC Section 4.1003(c). 3. Additionally, with regard to Tier 1 members who made the additional contribution authorized by LAAC Section 4.1003(c), the maximum amount of the annual increase authorized in LAAC Section 4.1111(b) is a vested benefit that shall be granted by the LACERS Board. 4. With regard to LACERS Tier 3, the Implementing Ordinance shall provide that all Tier 3 members shall contribute to LACERS four percent (4%) of their pre-tax compensation earnable toward vested retiree health benefits, and shall amend LAAC Division 4, Chapter 11 to provide the same vested benefits to all Tier 3 members as currently are provided to Tier 1 members who make the same four percent (4%) contribution to LACERS under the retiree health benefit program. 5. The entitlement to retiree health benefits under this provision shall be subject to the rules under LAAC Division 4, Chapter 11 in effect as of the effective date of this provision, and the rules that shall be placed into LAAC Division 4, Chapters 10 and 11, with regard to Tier 3, by the Implementing Ordinance. 6. As further provided herein, the amount of employee contributions is subject to bargaining in future MOU negotiations. 7. The vesting schedule for the Maximum Medical Plan Premium Subsidy for employees enrolled in LACERS Tier 1 and LACERS Tier 3 shall be the same. 8. Employees whose Health Service Credit, as defined in LAAC Division 4, Chapter 11, is based on periods of part-time and less than full-time employment, shall receive full, rather than prorated, Health Service Credit for periods of service. The monthly retiree medical subsidy amount to which these employees are entitled shall be prorated based on the extent to which their service credit is prorated due to their less than full time status.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!